Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 March 2022 | Story Bulelwa Moikwatlhai | Photo Supplied
International office
An international celebration. The Office for International Affairs hosted more than a hundred local and international students at the 2022 ‘Welcome to Mzansi’ event, integrating international students to life at the UFS.

On 18 March 2022, the Internationalisation at Home (I@H) portfolio in the Office for International Affairs at the University of the Free State (UFS) hosted its annual first-year international student welcome function themed ‘Welcome to Mzansi’ at the RAG farm. The function hosted more than one hundred local and international students who are part of the I@H integration initiative – the Umoja Buddy Programme. UFS students from the Arts and Culture division in Student Affairs set the tone for the evening with a drama presentation articulating a student’s first day in the UFS community, in Bloemfontein, and its surroundings. The drama showcased the diverse student community represented at the UFS.

A welcome video from the Rector and Vice-Chancellor of the university, Prof Francis Petersen, was shared with the students, highlighting how the past two years of the pandemic have equipped the students with key skills that they will use in the future. “I believe that the lessons you have learned will help you in the future, I know you will make an impact in your field. As a residential university, we welcome our students and staff back on campus in 2022 to learn, work, and socialise in a way that minimises risk but still provides our students with an on-campus student life.”

Prof Mudzi, the Director of the Postgraduate School, advocated the importance of furthering one’s studies. He stated, “You need to start working hard from day one of university education; the marks you get during your undergraduate years have a huge bearing on your future and your ability to progress to postgraduate studies, as it is highly dependent on the average mark you get at undergraduate level.” In his concluding remarks, Prof Mudzi advised the students to, “learn something new, engage with new people and cultures, enjoy South Africa, while succeeding in your studies at the UFS and working hard”.

Dr Hagenmeier, Director of the Office for International Affairs, delivered the keynote welcome address for the international students, with a brief introduction to the OIA staff. This, as outlined in his address, served the purpose of ensuring that students are familiar with the channels of communication, representatives, and office-bearers in specific portfolios under the OIA, as well as the functions of the OIA.

The evening ended off with musical performances by UFS students, while the attendees dined and networked over a hot plate of food. In the same spirit, the dance floor was opened. This was a very important part of integration, uniting the students regardless of their nationality, race, gender, etc. The students did not think twice about taking to the dance floor – seeing everyone dance made students who did not participate afraid that they were missing out.   


News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept